July 18 (Reuters) - Hanmi Pharm Co Ltd:
* HANMI PHARM CO LTD: Q2 OPERATING PROFIT UP 86% Y/Y TO 29.6 BILLION WON ($22.49 million) Further company coverage: ($1 = 1,316.4000 won)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
283,500 KRW | -1.05% | -4.87% | -19.57% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
July 18 (Reuters) - Hanmi Pharm Co Ltd:
* HANMI PHARM CO LTD: Q2 OPERATING PROFIT UP 86% Y/Y TO 29.6 BILLION WON ($22.49 million) Further company coverage: ($1 = 1,316.4000 won)
1st Jan change | Capi. | |
---|---|---|
-19.57% | 2.6B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |